|Title:||The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma||Authors:||Huang, Yen-Hsiang
Chen, Jeremy J W
|Keywords:||Adenocarcinoma; Epidermal growth factor receptor mutation; Exon 19 deletion; Lung neoplasms; T790M||Issue Date:||Oct-2018||Publisher:||KOREAN CANCER ASSOCIATION||Journal Volume:||50||Journal Issue:||4||Start page/Pages:||1294||Source:||Cancer research and treatment : official journal of Korean Cancer Association||Abstract:||
The main objective of this study was to investigate the relationship among the clinical characteristics and the frequency of T790M mutation in advanced epidermal growth factor receptor (EGFR)‒mutant lung adenocarcinoma patients with acquired resistance after firstline EGFR‒tyrosine kinase inhibitor (TKI) treatment.
|Appears in Collections:||毒理學研究所|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.